Related Experiment Videos

Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus

Insights

High-level gentamicin resistance in Streptococcus faecalis is increasing. Resistance is often plasmid-mediated and appears on diverse plasmids, not solely clonal spread.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • High-level aminoglycoside resistance (HLAR) in Enterococcus faecalis is a growing clinical concern.
  • HLAR significantly complicates treatment of serious enterococcal infections.

Purpose of the Study:

  • To investigate the prevalence and genetic basis of high-level gentamicin resistance (HLAR) in clinical isolates of Streptococcus faecalis.
  • To determine if resistance is associated with specific plasmids or clonal spread.

Main Methods:

  • Agarose gel electrophoresis was used to analyze plasmid DNA.
  • Filter matings were performed to assess the transferability of resistance.
  • Restriction enzyme analysis characterized plasmid heterogeneity.

Main Results:

  • 48 of 3,458 isolates (1.4%) showed high-level gentamicin resistance.
  • Resistance was transferable via plasmids in 44 isolates.
  • Gentamicin resistance was found on diverse, physically distinct plasmids, sometimes with other resistance markers.

Conclusions:

  • The increased frequency of gentamicin-resistant S. faecalis is likely due to the acquisition of resistance on various plasmids, rather than clonal dissemination.
  • Understanding plasmid-mediated resistance is crucial for managing infections caused by these strains.

Related Concept Videos